V. Galavotti

Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience

G. Donno, M. Franchini, G. Lucchini, 2022, Life.

Non-invasive mechanical ventilation in patients with diffuse interstitial lung diseases

R. Scala, S. Harari, F. Blasi, 2014, BMC Pulmonary Medicine.

Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?

E. Lalli, G. Gasbarrini, R. Borzì, 1990, Thorax.

Complement activation products in idiopathic pulmonary fibrosis: relevance of fragment Ba to disease severity.

D. Vergani, G. Senaldi, G. Gasbarrini, 1990, Clinical immunology and immunopathology.

MR889, a neutrophil elastase inhibitor, in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled clinical trial.

U. Kucich, V. Peona, B. Starcher, 1996, The European respiratory journal.

Effects of beta-agonists on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.

V. Galavotti, C. Sturani, S. Papiris, 1986, Respiration; international review of thoracic diseases.

Acute respiratory failure, due to severe obstructive sleep apnoea syndrome, managed with nasal positive pressure ventilation.

V. Galavotti, C. Scarduelli, D. Sella, 1994, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Pulmonary vascular responsiveness at rest and during exercise in idiopathic pulmonary fibrosis: effects of oxygen and nifedipine.

G. Gunella, V. Galavotti, C. Sturani, 1986, Respiration; international review of thoracic diseases.

Outcome of COPD patients performing nocturnal non-invasive mechanical ventilation.

N. Ambrosino, M. Vitacca, E. Clini, 1998, Respiratory medicine.

Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.

G. Gasbarrini, C. Negri, G. C. A. Astaldi Ricotti, 1989, Clinical and experimental immunology.